Nabilone Dosing
For refractory chemotherapy-induced nausea and vomiting, start nabilone at 1 mg twice daily (or 1 mg the night before and 1-2 hours before chemotherapy), titrating up to a maximum of 2 mg four times daily (6 mg/day total), with no dose adjustments required for renal or hepatic impairment. 1, 2
Standard Dosing Regimen
Initial Dose
- Start with 1 mg twice daily 2
- Alternatively, give 1 mg the night before chemotherapy, then 1-2 mg given 1-3 hours before the chemotherapeutic agent 2
- The lower starting dose minimizes side effects while establishing tolerance 2
Titration Schedule
- Increase gradually as needed using a "start low, go slow" approach 1
- Titration should be individualized based on antiemetic response and tolerability
- Continue dosing 2-3 times daily throughout the entire chemotherapy cycle 2
- May continue for up to 48 hours after the last dose of each chemotherapy cycle 2
Maximum Daily Dose
- 6 mg per day, divided into three doses (2 mg four times daily maximum) 1, 2
- This represents the ceiling dose beyond which additional benefit is unlikely and adverse effects increase
Special Population Adjustments
Hepatic Impairment
- No dose modifications required 1
- This is notable given nabilone's extensive hepatic metabolism via multiple P450 isoforms 2
- However, exercise heightened caution as the effects of hepatic dysfunction on nabilone elimination have not been formally studied 2
Renal Impairment
- No dose modifications required 1
- Only 22-24% of nabilone is eliminated renally; the biliary system is the major excretory pathway 2
- The pharmacokinetic profile in renal insufficiency has not been formally investigated 2
Elderly Patients
- Use the same dosing as younger adults, but with increased vigilance 1
- The pharmacokinetic profile has not been specifically studied in geriatric patients 2
- Elderly patients with cancer and polypharmacy face higher risk of adverse effects and drug interactions 1
- Monitor closely for sedation, dizziness, confusion, and orthostatic hypotension, which are more problematic in this population
Critical Clinical Considerations
Timing Relative to Chemotherapy
The FDA label specifies precise timing: administer the first dose 1-3 hours before chemotherapy to achieve peak plasma concentrations (reached at approximately 2 hours) when antiemetic effect is most needed 2
Common Pitfalls to Avoid
Dose-limiting adverse effects are frequent and include 1, 2:
- Drowsiness, dizziness, and vertigo (60-70% of patients)
- Euphoria and dysphoria
- Dry mouth
- Orthostatic hypotension
- Confusion and disorientation (especially at higher doses)
Key safety measures:
- Patients should remain under supervision of a responsible adult while using nabilone 2
- Warn patients about delayed onset (30 minutes to 2 hours) and prolonged duration (5-8 hours) of oral effects 1
- Avoid concurrent alcohol or barbiturates due to additive CNS depression 2
- The 2024 ASCO guideline emphasizes that adverse effects can be "a significant dose-limiting barrier, especially for adults with cancer and advanced age who frequently experience polypharmacy" 1
Context of Use
Nabilone is reserved for refractory CINV after failure of guideline-concordant antiemetic prophylaxis with moderately or highly emetogenic chemotherapy 1. It represents one of several salvage options, alongside olanzapine (if not already used prophylactically) or other antiemetic classes 1.
Metabolite Accumulation
While nabilone itself has a 2-hour half-life, metabolites have a 35-hour half-life and may accumulate with repeated dosing, potentially exceeding parent drug concentrations 2. This explains why tolerance to euphoria and dry mouth develops rapidly during chronic use 2, 3, but also why some adverse effects may persist or worsen.